A Phase 1, Open-label, Single-dose Study to Evaluate the Effect of Moderate or Severe Renal Impairment on the Pharmacokinetics of Inavolisib
Kidney Disorder Renal Failure Healthy Volunteers
For the latest version of this information please go to www.forpatients.roche.com